NYSE:WST

West Pharmaceutical Services Q2 2026 Earnings Report

West Pharmaceutical Services logo
$351.07 +4.51 (+1.30%)
Closing price 03:59 PM Eastern
Extended Trading
$350.73 -0.34 (-0.10%)
As of 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

West Pharmaceutical Services EPS Results

Actual EPS
N/A
Consensus EPS
$2.08
Beat/Miss
N/A
One Year Ago EPS
N/A

West Pharmaceutical Services Revenue Results

Actual Revenue
N/A
Expected Revenue
$838.32 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

West Pharmaceutical Services Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Thursday, July 23, 2026
Conference Call Time
8:00AM ET

Conference Call Resources

West Pharmaceutical Services Earnings Headlines

Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
See More West Pharmaceutical Services Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like West Pharmaceutical Services? Sign up for Earnings360's daily newsletter to receive timely earnings updates on West Pharmaceutical Services and other key companies, straight to your email.

About West Pharmaceutical Services

West Pharmaceutical Services (NYSE:WST) is a global developer and manufacturer of components, systems and services that enable the containment and delivery of injectable drugs. The company focuses on high-quality packaging and delivery solutions for the pharmaceutical and biotech industries, producing primary drug packaging components and specialized drug delivery devices used for vaccines, biologics and other injectable therapies. West is known for its elastomeric closures, seals and polymer components that maintain sterility and compatibility with sensitive drug formulations.

In addition to component manufacturing, West provides engineered delivery systems and support services across the product lifecycle. Its offerings include stoppers and seals, custom-molded polymer parts, prefillable syringe systems and a range of delivery device technologies for self-administration. The company also offers development assistance, analytical testing, regulatory support and contract manufacturing, helping customers take complex parenteral products from design through commercial production while meeting stringent quality and compliance requirements.

West serves a global customer base that includes large pharmaceutical companies, emerging biotech firms and contract development and manufacturing organizations. The company operates manufacturing, research and development, and quality centers across multiple regions to support international supply chains and regulatory markets in North America, Europe, Asia-Pacific and Latin America. With an emphasis on innovation and quality control, West positions itself as a partner for customers seeking reliable containment and delivery solutions for advanced injectable therapies.

View West Pharmaceutical Services Profile